Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Broker Notes
The Cochlear (ASX:COH) share price is down 8% in 4 weeks. Is it a buy?
Earnings Results
How have ASX healthcare shares performed during the August 2021 earnings season?
Blue Chip Shares
2 fantastic ASX 50 shares that analysts rate as buys
Healthcare Shares
The Cochlear (ASX: COH) share price is up 4% this last week
Growth Shares
3 fantastic ASX shares that could be buys
Share Fallers
August wasn't a great month for the Cochlear (ASX:COH) share price
Broker Notes
Leading brokers name 3 ASX shares to sell today
Share Market News
The ASX reporting wrap-up: Cochlear, Sydney Airport, TPG
Share Fallers
Cochlear (ASX:COH) share price sinks: How did its result compare to expectations?
Share Fallers
Why Cochlear, Santos, St Barbara, & TPG shares are dropping
Healthcare Shares
The Cochlear (ASX:COH) share price tumbles 7% despite dividend boost
Share Market News
ASX 200 midday update: Cochlear & TPG sink, Inghams jumps
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
